<?xml version="1.0" encoding="UTF-8"?>
<p id="Par19">General mortality rates are difficult to evaluate due to the lack of data on non-symptomatic cases, as in most countries universal microbiological screening for COVID-19 has not been implemented, thus leading to an overestimation of the prevalence of case fatality. As indicated, in China the overall fatality rate was 2.3% and in people with diabetes it was 7.3% [
 <xref ref-type="bibr" rid="CR1">1</xref>]. Data published in Italy, indicate that more than 70% of patients who died due to COVID-19 had either diabetes, cardiovascular disease or cancer as comorbidities [
 <xref ref-type="bibr" rid="CR7">7</xref>].
</p>
